The Journal of Immunology, Vol 159, Issue 12 6070-6076, Copyright © 1997 by American Association of Immunologists

ARTICLES

Determination of adenosine deaminase binding domain on CD26 and its immunoregulatory effect on T cell activation

RP Dong, K Tachibana, M Hegen, Y Munakata, D Cho, SF Schlossman and C Morimoto
Department of Medicine, Harvard Medical School, Boston, MA 02115, USA.

CD26, a 110-kDa cell surface glycoprotein, exhibits dipeptidyl peptidase IV enzyme activity and plays an important role in T cell costimulation. In the present study, we examined both the exact adenosine deaminase (ADA) binding domain on CD26 and the functional consequences of mutated CD26 transfectants that were deficient for cell surface ADA. Using CD26 deletion, human-rat swap, and point mutations, we found that the residues of L340, V341, A342, and R343 on the CD26 molecule were essential amino acids for ADA binding. When these amino acids were mutated and transfected into Jurkat cells, the resultant CD26 transfectants expressed only CD26, not ADA, on the cell surface. The amount of IL-2 produced by wild-type and mutated CD26 transfectants was almost the same following stimulation with anti-CD3 plus PMA. However, the mutated CD26 transfectants were much more sensitive to the inhibitory effect of adenosine on IL-2 production than were the wild CD26 transfectants. These data suggest that ADA on the cell surface does not directly involve T cell activation. Conversely, CD26 alone does not result in modulating the inhibitory effect of adenosine. Only the ADA bound to CD26 on the cell surface was functional and could counteract the inhibitory effect of elevated extracellular adenosine.

This article has been cited by other articles:

				N. Busso, N. Wagtmann, C. Herling, V. Chobaz-Peclat, A. Bischof-Delaloye, A. So, and E. Grouzmann Circulating CD26 Is Negatively Associated with Inflammation in Human and Experimental Arthritis Am. J. Pathol., February 1, 2005; 166(2): 433 - 442. [Abstract] [Full Text] [PDF]

				W. A. Weihofen, J. Liu, W. Reutter, W. Saenger, and H. Fan Crystal Structure of CD26/Dipeptidyl-peptidase IV in Complex with Adenosine Deaminase Reveals a Highly Amphiphilic Interface J. Biol. Chem., October 8, 2004; 279(41): 43330 - 43335. [Abstract] [Full Text] [PDF]

				M. Gonzalez-Gronow, M. S. Hershfield, F. X. Arredondo-Vega, and S. V. Pizzo Cell Surface Adenosine Deaminase Binds and Stimulates Plasminogen Activation on 1-LN Human Prostate Cancer Cells J. Biol. Chem., May 14, 2004; 279(20): 20993 - 20998. [Abstract] [Full Text] [PDF]

				E. P. Boonacker, E. A. Wierenga, H. H. Smits, and C. J.F. Van Noorden CD26/DPPIV Signal Transduction Function, but Not Proteolytic Activity, Is Directly Related to Its Expression Level on Human Th1 and Th2 Cell Lines as Detected with Living Cell Cytochemistry J. Histochem. Cytochem., September 1, 2002; 50(9): 1169 - 1177. [Abstract] [Full Text] [PDF]

				E. Richard, S. M. Alam, F. X. Arredondo-Vega, D. D. Patel, and M. S. Hershfield Clustered Charged Amino Acids of Human Adenosine Deaminase Comprise a Functional Epitope for Binding the Adenosine Deaminase Complexing Protein CD26/Dipeptidyl Peptidase IV J. Biol. Chem., May 24, 2002; 277(22): 19720 - 19726. [Abstract] [Full Text] [PDF]

				O. J. Cordero, F. J. Salgado, C. M. Fernandez-Alonso, C. Herrera, C. Lluis, R. Franco, and M. Nogueira Cytokines regulate membrane adenosine deaminase on human activated lymphocytes J. Leukoc. Biol., December 1, 2001; 70(6): 920 - 930. [Abstract] [Full Text] [PDF]

				K. J. Homma, Y. Tanaka, T. Matsushita, K. Yokoyama, H. Matsui, and S. Natori Adenosine Deaminase Activity of Insect-derived Growth Factor Is Essential for Its Growth Factor Activity J. Biol. Chem., November 16, 2001; 276(47): 43761 - 43766. [Abstract] [Full Text] [PDF]

				U. Aytac, F.-X. Claret, L. Ho, K. Sato, K. Ohnuma, G. B. Mills, F. Cabanillas, C. Morimoto, and N. H. Dang Expression of CD26 and Its Associated Dipeptidyl Peptidase IV Enzyme Activity Enhances Sensitivity to Doxorubicin-induced Cell Cycle Arrest at the G2/M Checkpoint Cancer Res., October 1, 2001; 61(19): 7204 - 7210. [Abstract] [Full Text] [PDF]

				J. SAMPOL, B. DUSSOL, E. FENOUILLET, C. CAPO, J.-L. MEGE, G. HALIMI, G. BECHIS, P. BRUNET, H. ROCHAT, Y. BERLAND, et al. High Adenosine and Deoxyadenosine Concentrations in Mononuclear Cells of Hemodialyzed Patients J. Am. Soc. Nephrol., August 1, 2001; 12(8): 1721 - 1728. [Abstract] [Full Text] [PDF]

				C. Herrera, V. Casadó, F. Ciruela, P. Schofield, J. Mallol, C. Lluis, and R. Franco Adenosine A2B Receptors Behave as an Alternative Anchoring Protein for Cell Surface Adenosine Deaminase in Lymphocytes and Cultured Cells Mol. Pharmacol., January 1, 2001; 59(1): 127 - 134. [Abstract] [Full Text]

				E. Richard, F. X. Arredondo-Vega, I. Santisteban, S. J. Kelly, D. D. Patel, and M. S. Hershfield The Binding Site of Human Adenosine Deaminase for CD26/Dipeptidyl Peptidase IV: The Arg142Gln Mutation Impairs Binding to CD26 but Does Not Cause Immune Deficiency J. Exp. Med., October 30, 2000; 192(9): 1223 - 1236. [Abstract] [Full Text] [PDF]

				H. Ikushima, Y. Munakata, T. Ishii, S. Iwata, M. Terashima, H. Tanaka, S. F. Schlossman, and C. Morimoto Internalization of CD26 by mannose 6-phosphate/insulin-like growth factor II receptor contributes to T cell activation PNAS, July 18, 2000; 97(15): 8439 - 8444. [Abstract] [Full Text] [PDF]

				Y. Kumagai, K. Konishi, T. Gomi, H. Yagishita, A. Yajima, and M. Yoshikawa Enzymatic Properties of Dipeptidyl Aminopeptidase IV Produced by the Periodontal Pathogen Porphyromonas gingivalis and Its Participation in Virulence Infect. Immun., February 1, 2000; 68(2): 716 - 724. [Abstract] [Full Text] [PDF]